Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Lilly announced that ATTAIN-3 was the third successful Phase 3 trial, triggering global regulatory submissions for obesity in 2025
GLP-1 receptor agonists, by contrast, mimic glucagon-like peptide-1, a hormone your intestines naturally produce after eating
Whether youre studying tissue repair, enhanced recovery, or peptide mechanisms, its exceptional quality ensures precision across diverse research methodologies
NAD (Nicotinamide Adenine Dinucleotide) Considered for its cellular energy support role
US$ 27.95
US$ 22.95
US$ 28.29
US$ 27.04
US$ 24.45
US$ 27.31
US$ 26.73
US$ 20.72
US$ 21.03
